Cargando…

First case of B ALL with KMT2A-MAML2 rearrangement: a case report

BACKGROUND: A large number of chromosomal translocations of the human KMT2A gene, better known as the MLL gene, have so far been characterized. Genetic rearrangements involving KMT2A gene are frequently involved in lymphoid, myeloid and mixed lineage leukemia. One of its rare fusion partners, the ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menu, Estelle, Beaufils, Nathalie, Usseglio, Fabrice, Balducci, Estelle, Lafage Pochitaloff, Marina, Costello, Regis, Gabert, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442694/ https://www.ncbi.nlm.nih.gov/pubmed/28535805 http://dx.doi.org/10.1186/s12885-017-3368-4

Ejemplares similares

Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma
por: Thierauf, Julia C., et al.
Publicado: (2022)

B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL
por: Fournier, Benjamin, et al.
Publicado: (2019)

Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL
por: Kang, Huining, et al.
Publicado: (2018)

MAML2 Rearrangement in Primary Pulmonary Mucoepidermoid Carcinoma and the Correlation with FLT1 Expression
por: Zhu, Fen, et al.
Publicado: (2014)

IGH Rearrangement Evolution in Adult KMT2A-rearranged B-cell Precursor ALL: Implications for Cell-of-origin and MRD Monitoring
por: Darzentas, Franziska, et al.
Publicado: (2022)

MAML2-Rearranged Primary Central Mucoepidermoid Carcinoma of the Mandible as an Incidental Finding: A Case Report and Review of the Literature of Molecularly Confirmed Cases
por: Aguirre, Sarah E., et al.
Publicado: (2023)

P315: TP53 ALTERATIONS AND MRD REFINE PROGNOSIS OF ADULT KMT2A-REARRANGED B-ALL
por: Kim, Rathana, et al.
Publicado: (2023)

PAX5 alterations in an infant case of KMT2A‐rearranged leukemia with lineage switch
por: Nakajima, Koji, et al.
Publicado: (2022)

Poromas with YAP1–MAML2 fusions in a poromatosis case
por: Yamamoto, Masako, et al.
Publicado: (2022)

Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements
por: Issa, Ghayas C., et al.
Publicado: (2021)

Significance of YAP1–MAML2 rearrangement and GTF2I mutation in the diagnosis and differential diagnosis of metaplastic thymoma
por: Wang, Minghao, et al.
Publicado: (2023)

MAML2-Rearranged Mucoepidermoid Carcinoma of the Parotid Gland: A Report in a 20-Month-Old Toddler
por: Owosho, Adepitan A., et al.
Publicado: (2022)

Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions
por: Massoth, Lucas R., et al.
Publicado: (2020)

KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints
por: Bataller, Alex, et al.
Publicado: (2021)

A Rare Case of Exclusively Oncocytic Mucoepidermoid Carcinoma with MAML2 Translocation
por: Liao, Xiaoyan, et al.
Publicado: (2016)

Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias
por: Lopes, Bruno A., et al.
Publicado: (2022)

PB1799: KMT2A-REARRANGED PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Zerkalenkova, E., et al.
Publicado: (2022)

Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia
por: Górecki, Mateusz, et al.
Publicado: (2023)

MAML2 rearrangement as a useful diagnostic marker discriminating between Warthin tumour and Warthin-like mucoepidermoid carcinoma
por: Bieńkowski, Michał, et al.
Publicado: (2020)

The Partial Duplication of the 5′ Segment of KMT2A Revealed KMT2A-MLLT10 Rearrangement in a Boy with Acute Myeloid Leukemia
por: Fukushima, Hiroko, et al.
Publicado: (2017)

Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
por: Richard-Carpentier, Guillaume, et al.
Publicado: (2021)

Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
por: Tsakaneli, Alexia, et al.
Publicado: (2021)

Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia
por: Cheung, Laurence C., et al.
Publicado: (2021)

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
por: Issa, Ghayas C., et al.
Publicado: (2023)

Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens
por: Wright, Shaela, et al.
Publicado: (2023)

YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor
por: Agaimy, Abbas, et al.
Publicado: (2020)

Primary mucoepidermoid carcinoma of the liver with CRTC1-MAML2 fusion: a case report
por: Watanabe, Jiro, et al.
Publicado: (2019)

Effects of the MAML2 genetic variants in glioma susceptibility and prognosis
por: Zhang, Ming, et al.
Publicado: (2019)

Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells
por: Nanya, Mai, et al.
Publicado: (2015)

B‐cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement
por: Kemps, Paul G., et al.
Publicado: (2020)

Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia
por: Hoffmeister, Lina Marie, et al.
Publicado: (2021)

Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma
por: Au-Yeung, Rex K. H., et al.
Publicado: (2022)

Palbociclib in Acute Leukemias With KMT2A-rearrangement: Results of AMLSG 23-14 Trial
por: Gaidzik, Verena I., et al.
Publicado: (2023)

Monocytic and blastic plasmacytoid dendritic cell differentiation in acute leukemia with KMT2A rearrangement
por: Xue, Owen, et al.
Publicado: (2023)

Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A-Rearranged Acute Lymphoblastic Leukemia
por: Eadie, Laura N., et al.
Publicado: (2023)

Mucoepidermoid carcinoma of the sublingual gland harboring a translocation of the MAML2 gene: A case report
por: Sato, Kiminobu, et al.
Publicado: (2017)

Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia
por: Tregnago, Claudia, et al.
Publicado: (2022)

A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia
por: Harada, Taku, et al.
Publicado: (2022)

P435: NOVEL COMPOUNDS TO TARGET KMT2A-REARRANGED PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Tregnago, Claudia, et al.
Publicado: (2023)

Acute myeloid leukaemia at an early age: Reviewing the interaction between pesticide exposure and KMT2A-rearrangement
por: Pombo-de-Oliveira, Maria S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f9o17f8q098j9skuhe7rf0vsjb